Pharmaceutical Water Market: Demand, Supply and Technological Advancements

The global pharmaceutical water market has been experiencing significant growth, with the market size estimated at US$ 38.70 billion in 2023. Forecasts indicate that this growth will continue, and the market is projected to reach US$ 107.15 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.25% from 2024 to 2034. This expansion reflects the increasing importance of high-quality water in the pharmaceutical industry, which is crucial for a variety of medical and non-medical uses.

Download Statistical Data: https://www.towardshealthcare.com/download-statistics/5225

Market Overview and Key Insights

North America emerged as the dominant player in the pharmaceutical water market in 2023, commanding 35% of the market share. The region's well-established pharmaceutical industry and stringent regulations for water quality have contributed to this market dominance. However, Asia Pacific is expected to grow at the fastest rate, with a projected CAGR of 10.34% during the forecast period. The rise in pharmaceutical manufacturing activities in countries like China and India, driven by a growing demand for healthcare products, is fueling this surge in the Asia Pacific region.

Market Segmentation: Types and Applications

The pharmaceutical water market can be divided into different types and applications, each serving a specific function within the pharmaceutical and biotechnology industries.

By Type:

In 2023, the Water for Injection (WFI) segment held the largest share of the market, accounting for 79%. Water for Injection is essential in the production of injectable medications, as it must meet rigorous sterility and quality standards. This segment's dominance reflects the growing demand for high-purity water in the manufacturing of pharmaceutical products that require injection, such as biologics and injectables.

Other types of pharmaceutical water include bulk purified water, bulk highly purified water, and drinking water, each playing an important role in the manufacturing processes. Bulk purified water is commonly used in the preparation of pharmaceuticals, while highly purified water is often required for the production of high-value products like APIs (Active Pharmaceutical Ingredients) and diagnostics.

By Application:

In terms of applications, the pharmaceutical and biotechnology companies segment led the market in 2023, holding 58% of the market share. This segment continues to be the largest contributor due to the increasing demand for pharmaceutical products, including generic drugs, vaccines, and biologics. Water is used as a critical raw material, excipient, and solvent in the formulation, processing, and manufacturing of these products. Additionally, pharmaceutical water is vital in the production of APIs and intermediates, which are crucial components in drug manufacturing.

The Dual Role of Pharmaceutical Water: Medical and Non-Medical Use
Pharmaceutical water plays a vital role not only in the medical sector but also in non-medical applications.

Medical Uses:

Water is used in the pharmaceutical industry for numerous medical purposes. It serves as a raw material, solvent, and excipient in the formulation of medicines, ensuring that the final products are safe and effective for consumption. Pharmaceutical water is involved in the synthesis and manufacturing of various Active Pharmaceutical Ingredients (APIs), analytical reagents, and intermediates, contributing to the production of finished drug products.

Moreover, pharmaceutical water is essential in the reconstitution of pharmaceutical products, which involves mixing powdered drugs with water to create a liquid form for administration. It also serves as a key excipient in certain drug formulations and plays a pivotal role in drug synthesis processes.

Non-Medical Uses:

In addition to its medical applications, pharmaceutical water is utilized in non-medical activities, such as cleaning and rinsing vessels, primary packaging materials, and equipment used in the manufacturing process. High-purity water ensures that pharmaceutical manufacturing environments remain contaminant-free, preventing impurities from compromising the integrity of the final products. Cleaning and sanitization are essential to maintaining the safety and quality of pharmaceutical products.
Artificial Intelligence's Role in Revolutionizing the Pharmaceutical Water Market

The pharmaceutical water market, a critical component in the production of biopharmaceuticals and other therapeutic products, has seen remarkable advancements in recent years. As the industry expands, there is an increasing need for high-quality pharmaceutical water to support the production of life-saving medications. Artificial intelligence (AI) is playing a pivotal role in enhancing the quality, efficiency, and sustainability of water treatment systems, thereby significantly influencing the pharmaceutical water market.

AI: A Game Changer for Water Quality and Treatment

AI technologies are transforming water treatment systems in profound ways, offering real-time insights and predictive capabilities that improve water quality and optimize treatment processes. AI-driven smart control systems are capable of forecasting fluctuations in water demand and adjusting treatment processes accordingly, ensuring a consistent and high-quality water supply for pharmaceutical production. This not only improves overall treatment standards but also reduces energy consumption, making the entire process more efficient and cost-effective.

One of the most significant benefits of AI in water treatment is the development

of intelligent filtration systems. These systems utilize advanced AI algorithms and sensors to monitor and adapt to changing water quality conditions. By detecting specific pollutants, AI-powered filtration systems can automatically adjust filtration procedures to target the precise contaminants present in the water. This ensures comprehensive purification while minimizing the risk of harmful substances entering the water supply. Moreover, AI's ability to predict and prevent equipment failures before they occur helps reduce downtime, thereby facilitating autonomous maintenance and further enhancing the efficiency of water purification systems.

Biopharmaceuticals and Biosimilars Driving Pharmaceutical Water Demand

The growing demand for biopharmaceuticals and biosimilars is one of the key drivers of the pharmaceutical water market. Biopharmaceuticals, including recombinant proteins, monoclonal antibodies, cell and gene therapies, and vaccines, are becoming increasingly vital in the treatment of chronic diseases, genetic disorders, and cancer. These therapies are often tailored to meet the individual needs of patients, offering personalized treatment options that improve patient outcomes.

As the global demand for biopharmaceuticals and biosimilars continues to rise, pharmaceutical companies are ramping up production to meet the needs of healthcare providers and patients. This surge in production directly correlates with an increased demand for pharmaceutical-grade water, which is essential in the manufacturing process. Water is used not only in the formulation of therapeutic products but also in the research and development of new treatments and drugs. With more companies focusing on the large-scale production of these vital treatments, the pharmaceutical water market is expected to see significant growth in the coming years.

Testing Costs: A Barrier to Market Expansion

Despite the growing demand for pharmaceutical water, the market faces certain challenges. One of the major obstacles is the high cost of testing required to ensure the water meets stringent safety and quality standards. Pharmaceutical water undergoes a series of rigorous tests, including Total Organic Carbon (TOC) testing, endotoxin testing, bioburden testing, and Water for Injection (WFI) testing, among others. These tests are essential to ensure the water's purity and safety, as impurities can compromise the efficacy and safety of pharmaceutical products.

However, the cost of conducting these tests can be substantial, requiring significant financial investment from pharmaceutical companies. With the increasing demand for pharmaceutical water, the testing process becomes more resource-intensive, placing a strain on company budgets. While these tests are unavoidable, there is an opportunity to reduce costs and enhance efficiency through the integration of advanced technologies such as AI and machine learning. These technologies can automate data analysis, improve test accuracy, and ultimately reduce the financial burden on companies, creating a more cost-effective testing process and contributing to market growth.

Advancements in Water Purification Technologies

The pharmaceutical water market is also poised for growth through the continued advancement of water purification technologies. With the global shortage of water becoming an ever-more pressing concern, the demand for efficient and sustainable water purification systems is on the rise. Modern water purification technologies, including reverse osmosis, ultraviolet (UV) oxidation, distillation, electrodeionization, and ultrafiltration, play a crucial role in ensuring that pharmaceutical water meets the necessary quality standards.

To address the growing need for sustainable water purification, new technologies are emerging that aim to improve efficiency and reduce resource consumption. Innovations in Total Organic Carbon (TOC) monitoring, data analytics for predictive maintenance, and remote system access are creating new opportunities for the pharmaceutical water market. These technologies can help pharmaceutical companies achieve better water quality while minimizing waste and conserving valuable resources.

A prime example of such innovation was the launch of DataShare Elite by SUEZ - Water Technologies & Solutions in July 2022. This data management software platform is designed for use with Sievers Total Organic Carbon (TOC) Analyzers, allowing pharmaceutical manufacturers to centralize conductivity and TOC data from various sources. The software enhances decision-making by providing real-time insights while maintaining compliance with industry standards. Additionally, it streamlines the approval and evaluation of data, improving process control and making analytical testing more efficient. With such advancements in technology, the pharmaceutical water market is well-positioned for further growth and development.

Exploring the Pharmaceutical Water Market: Trends, Growth Drivers, and Regional Insights

The pharmaceutical water market plays a critical role in the development and production of pharmaceutical products. As an essential component in the formulation of injectable medicines and the manufacturing processes of drugs, water quality and availability are pivotal in ensuring the safety and efficacy of medicinal solutions. The market dynamics are shaped by growing demands in pharmaceutical research and the ever-expanding biopharmaceutical sector. This article delves into the key trends driving the market, the regional shifts influencing its growth, and the leading players shaping its future.

Water for Injection: The Dominant Segment in 2023

In 2023, the water for injection (WFI) segment led the pharmaceutical water market, commanding a dominant share of 79%. WFI is a high-quality sterile water used to make injectable solutions and to dissolve or dilute drugs for intravenous use. Its primary function is to provide a solvent that preserves the integrity of drugs and ensures their safe absorption into the human body.

Water for injection is subject to stringent quality standards set by regulatory bodies, such as the U.S. Pharmacopeia, which dictates the permissible levels of organic carbon, endotoxins, and microbial contamination. This ensures that the water used in drug formulations is safe and uncontaminated. The increasing reliance on injectable medicines and biopharmaceuticals further bolsters the demand for WFI, with its applications spanning across the production of vaccines, biologics, and therapeutic drugs.

An example of recent advancements in this area was witnessed in July 2022, when ILC Dover LP introduced WFI solutions tailored for the biotherapeutics industry. This innovation caters to the needs of pharmaceutical processing, especially in the production of buffers, media, and components for medical devices and biopharmaceuticals.

Pharmaceutical & Biotechnology Companies Drive Market Growth

By application, pharmaceutical and biotechnology companies represented the largest share of the pharmaceutical water market in 2023, with a significant 58% share. The demand for pharmaceutical water in these sectors has been growing steadily due to the escalating need for new therapeutics, especially for chronic diseases, rare conditions, and neglected illnesses that lack targeted treatments.

These companies invest heavily in research and development (R&D), and collaborations with government entities to conduct clinical trials and drug discovery. This consistent investment in new treatments is set to drive the demand for pharmaceutical water in the coming years, particularly as the scale of production increases alongside the development of new biologics, vaccines, and personalized therapies.

A notable development within the pharmaceutical and biotechnology sectors occurred in July 2024 when Evotec SE announced a multi-year collaboration with Pfizer. The partnership, focused on early discovery research for infectious and metabolic diseases, highlights the growing need for pharmaceutical water in supporting the production and development of cutting-edge treatments.

Similarly, in March 2024, a strategic partnership between Ono Pharmaceutical Co., Ltd. and Sibylla Biotech was established to develop new treatments for neurological diseases. These partnerships signal the significant investments in drug development that will continue to drive the pharmaceutical water market.

North America: The Leading Region in the Pharmaceutical Water Market

In 2023, North America led the pharmaceutical water market, holding a 35% share. The region is home to some of the world's largest pharmaceutical and biotechnology companies, making it a key player in the global pharmaceutical water market. Technological advancements, coupled with a strong presence of regulatory bodies like the U.S. Food and Drug Administration (FDA), further support the region's dominance.

The U.S. remains the largest market within North America, contributing significantly to the global pharmaceutical water demand. In 2023, the FDA approved 55 new drugs, including biologics, small molecules, and targeted therapeutics, which in turn fueled the need for pharmaceutical water in drug development and manufacturing. Investment from international markets has further bolstered the U.S. pharmaceutical sector, with countries such as Germany, Japan, the U.K., and Switzerland investing billions of dollars in the U.S. pharmaceutical industry.

The Canadian market also plays a crucial role in North America's pharmaceutical water demand. Government investments have been pivotal in enhancing the country's pharmaceutical capabilities. Noteworthy investments include the 2023 allocation of US$29.77 million to Pharmascience Inc. for the expansion of sterile injectables facilities, demonstrating Canada's growing influence in the pharmaceutical sector.

Asia Pacific: A Rapidly Expanding Market with Strong Growth Potential

Asia Pacific is expected to grow at the fastest rate, with a projected compound annual growth rate (CAGR) of 10.34% during the forecast period. The pharmaceutical water market in this region is thriving, driven by countries like India, China, Japan, and South Korea. India, in particular, has emerged as a major player in the global pharmaceutical industry due to its cost-effective production capabilities, a large domestic market, and significant government investment in the sector.

India's pharmaceutical industry, ranked third globally in terms of volume, is projected to reach $50 billion in market value. The country's pharmaceutical sector accounts for 23% of global water usage, which underscores the growing demand for high-quality pharmaceutical water. India is also set to become a leader in drug production, contributing significantly to the global supply of generics, biosimilars, and vaccines.

To further accelerate this growth, the Indian government introduced the Production Linked Incentive (PLI) scheme with a budget of INR 15,000 crore until 2027-2028. This initiative aims to boost domestic manufacturing of critical pharmaceutical ingredients, driving the demand for pharmaceutical water in the process. With Vision Pharma 2047 goals, India is setting ambitious targets for the development of innovative and affordable healthcare products, reinforcing its position as a key player in the pharmaceutical water market.

Key Players in the Pharmaceutical Water Market

• Baxter International, Inc.
• Asahi Kasei
• Intermountain Life Sciences
• Thermo Fisher Scientific, Inc.
• Veolia Water Technologies
• CovaChem, LLC
• Fresenius Kabi AG
• Cytiva (Danaher)
• Merck KGaA
• Pfizer, Inc.
• Braun Melsungen AG

Recent Developments in the Pharmaceutical Water Market

The pharmaceutical water market continues to witness innovations and advancements aimed at ensuring purity, reliability, and ease of use for critical pharmaceutical applications. Several key developments have recently emerged, reinforcing the importance of ultrapure water (UPW) and cutting-edge technologies that support its production and application.

Sartorius Launches the Arium® Mini Extend: A Compact Solution for Ultrapure Water

In June 2024, Sartorius, a leading life sciences company, introduced the Arium® Mini Extend, the latest member of its Arium® Mini family. This new laboratory water purification system is designed to meet the rigorous demands of Type 1 ultrapure water for various analytical, life science, and general applications. The Arium® Mini Extend is engineered to provide a compact and efficient solution for laboratories in need of high-quality water, particularly for sensitive experiments and processes.

What sets this system apart is its exceptional adaptability and user-friendliness. Its intuitive design allows researchers and scientists to access ultrapure water with minimal complexity, ensuring reliable performance in a wide range of laboratory environments. Whether used for routine analysis or more complex research, the Arium® Mini Extend is an invaluable tool for maintaining the high standards required in the pharmaceutical industry.

Avenacy's FDA-Approved Magnesium Sulfate for Injection Now Available

In May 2024, Avenacy, a prominent specialty pharmaceutical company specializing in essential injectable drugs, made an important announcement regarding the availability of magnesium sulfate in water for injection in the U.S. This product, which has received FDA approval, is a critical medication for the prevention and management of seizures associated with preeclampsia and eclampsia, conditions that affect pregnant women and can have severe consequences for both the mother and the child.

Magnesium sulfate is a widely used treatment in obstetric care, and its availability in water for injection form provides a reliable, ready-to-use option for healthcare providers. Avenacy's introduction of this product underscores its commitment to addressing the healthcare needs of vulnerable populations and reinforcing the significance of timely, high-quality injectable pharmaceuticals in the management of life-threatening conditions.

Veolia Water Technologies Introduces PURELAB® Pharma Compliance Package

In September 2023, Veolia Water Technologies UK (VWT UK) launched its PURELAB® Pharma Compliance package, designed for businesses that require a consistent supply of ultrapure water for quality control (QC) laboratories. This comprehensive solution addresses the need for stringent water purity in the pharmaceutical industry, where regulatory compliance and water quality are critical to ensuring the safety and efficacy of pharmaceutical products.

The PURELAB® Pharma Compliance package includes not only the necessary equipment for water purification but also validation and certification software to streamline the regulatory process. This tailored package provides everything a QC laboratory needs to meet the industry's high standards for water quality, ensuring that companies can maintain efficient and compliant operations. With the inclusion of user-friendly tools and services, Veolia Water Technologies is helping businesses optimize their water management while ensuring compliance with industry regulations.

Source: https://www.towardshealthcare.com/insights/pharmaceutical-water-market-sizing

Baner

Buy Premium Global Insight: https://www.towardshealthcare.com/price/5225

Review the Full TOC for the Pharmaceutical Water Market Report: https://www.towardshealthcare.com/table-of-content/pharmaceutical-water-market-sizing

Get the latest insights on industry segmentation with our Annual Membership https://www.towardshealthcare.com/get-an-annual-membership

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

We've prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

This release was published on openPR.